Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants ; volume:15 ; number:1 ; day:28 ; month:3 ; year:2024 ; pages:1-18 ; date:12.2024
Nature Communications ; 15, Heft 1 (28.3.2024), 1-18, 12.2024

Creator: Hayes, Tikvah K.
Aquilanti, Elisa
Persky, Nicole S.
Yang, Xiaoping
Kim, Erica E.
Brenan, Lisa
Goodale, Amy B.
Alan, Douglas
Sharpe, Ted
Shue, Robert E.
Westlake, Lindsay
Golomb, Lior
Silverman, Brianna R.
Morris, Myshal D.
Fisher, Ty Running
Beyene, Eden
Li, Yvonne Y.
Cherniack, Andrew D.
Piccioni, Federica
Hicks, J. Kevin
Chi, Andrew S.
Cahill, Daniel P.
Dietrich, Jorg
Batchelor, Tracy T.
Root, David E.
Johannessen, Cory M.
Meyerson, Matthew

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41467-024-45594-4

URN: urn:nbn:de:101:1-2406292125542.731773016634

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hayes, Tikvah K.
Aquilanti, Elisa
Persky, Nicole S.
Yang, Xiaoping
Kim, Erica E.
Brenan, Lisa
Goodale, Amy B.
Alan, Douglas
Sharpe, Ted
Shue, Robert E.
Westlake, Lindsay
Golomb, Lior
Silverman, Brianna R.
Morris, Myshal D.
Fisher, Ty Running
Beyene, Eden
Li, Yvonne Y.
Cherniack, Andrew D.
Piccioni, Federica
Hicks, J. Kevin
Chi, Andrew S.
Cahill, Daniel P.
Dietrich, Jorg
Batchelor, Tracy T.
Root, David E.
Johannessen, Cory M.
Meyerson, Matthew
SpringerLink (Online service)

Other Objects (12)

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Graffiti | Streetart

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

Graffiti | Streetart

TKi

Graffiti | Streetart

TKI

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Graffiti | Streetart

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

Graffiti | Streetart

TKi

Graffiti | Streetart

TKI

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

Graffiti | Streetart

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

Graffiti | Streetart

TKi

Graffiti | Streetart

TKI

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

TKi

TKI

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

TKi

TKI

Author Correction: Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants

NSCLC – Neuer TKI zeigt Wirksamkeit bei EGFR-Resistenzmutation

TKi | TKi

Osimertinib : Resistenz bei EGFR-mutiertem NSCL unter TKI-Behandlung

Therapeutic effect of whole brain radiotherapy on advanced NSCLC between EGFR TKI-naïve and TKI-resistant

Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: a multicenter retrospective study

Plasma metabolomics profiling of EGFR-mutant NSCLC patients treated with third-generation EGFR-TKI

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC

MET inhibitors for targeted therapy of EGFR TKI-resistant lung cancer

Enhanced YAP expression leads to EGFR TKI resistance in lung adenocarcinomas

TKi

TKI

Related objects

Reset password